Email
Print
Cancer/Tumor Profiling Market - Forecast(2024 - 2030)
1. Cancer/Tumor Profiling Market - Overview
1.1 Definitions and Scope
2. Cancer/Tumor Profiling Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Cancer/Tumor Profiling Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Cancer/Tumor Profiling Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Cancer/Tumor Profiling Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Cancer/Tumor Profiling Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Cancer/Tumor Profiling Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
11.1 Cancer/Tumor Profiling Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Cancer/Tumor Profiling- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Cancer/Tumor Profiling- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Cancer/Tumor Profiling - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Cancer/Tumor Profiling - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Cancer/Tumor Profiling Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Cancer/Tumor Profiling Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Cancer/Tumor Profiling Market - Key Company List by Country Premium
16.1 Abbreviations
16.2 Sources
17. Cancer/Tumor Profiling Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Cancer/Tumor Profiling Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Cancer/Tumor Profiling Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Cancer/Tumor Profiling Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Cancer/Tumor Profiling Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Cancer/Tumor Profiling Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Cancer/Tumor Profiling Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Cancer/Tumor Profiling Market - By Technology (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Immunoassays
8.3 Hybridization
8.3.1 PCR
8.3.2 In Situ Hybridization (ISH)
8.3.3 DNA/RNA Microarray
8.4 Next Generation Sequencing
8.5 Mass Spectrometry
8.6 Other Technologies
9. Cancer/Tumor Profiling Market - By Cancer Type (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Breast Cancer
9.3 Lung Cancer
9.4 Colorectal Cancer
9.5 Prostate Cancer
9.6 Melanoma Cancer
9.7 Others Cancer
10. Cancer/Tumor Profiling - By Application (Market Size -$Million / $Billion)
10.1 Introduction
10.2 Clinical Application
10.3 Research Application
11. Cancer/Tumor Profiling- By Geography (Market Size -$Million / $Billion)11.1 Cancer/Tumor Profiling Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Cancer/Tumor Profiling- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Cancer/Tumor Profiling- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Cancer/Tumor Profiling - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Cancer/Tumor Profiling - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Cancer/Tumor Profiling Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Cancer/Tumor Profiling Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Cancer/Tumor Profiling Market - Key Company List by Country Premium
15. Cancer/Tumor Profiling Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Caris Life Sciences
15.3 Genomic Health Inc.
15.4 Helomics Corporation
15.5 HTG Molecular Diagnostics, Inc.
15.6 Illumina, Inc.
15.7 Nanostring Technologies, Inc.
15.8 Neogenomics Laboratories, Inc.
15.9 Oxford Gene Technology
15.10 Qiagen N.V.
15.11 Ribomed Biotechnologies, Inc.
15.12 Company 11
15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Cancer/Tumor Profiling Market - Appendix16.1 Abbreviations
16.2 Sources
17. Cancer/Tumor Profiling Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Tumor Profiling Market, By Technology Market 2023-2030 ($M)1.1 Immunoassay Market 2023-2030 ($M) - Global Industry Research
1.2 Hybridization Market 2023-2030 ($M) - Global Industry Research
1.2.1 Pcr Market 2023-2030 ($M)
1.2.2 In Situ Hybridization Market 2023-2030 ($M)
1.2.3 Dna/Rna Microarray Market 2023-2030 ($M)
1.3 Next Generation Sequencing Market 2023-2030 ($M) - Global Industry Research
1.4 Mass Spectrometry Market 2023-2030 ($M) - Global Industry Research
2.Global Tumor Profiling Market, By Cancer Type Market 2023-2030 ($M)
2.1 Breast Cancer Market 2023-2030 ($M) - Global Industry Research
2.2 Lung Cancer Market 2023-2030 ($M) - Global Industry Research
2.3 Colorectal Cancer Market 2023-2030 ($M) - Global Industry Research
2.4 Prostate Cancer Market 2023-2030 ($M) - Global Industry Research
2.5 Melanoma Cancer Market 2023-2030 ($M) - Global Industry Research
3.Global Tumor Profiling Market, By Technology Market 2023-2030 (Volume/Units)
3.1 Immunoassay Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Hybridization Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Pcr Market 2023-2030 (Volume/Units)
3.2.2 In Situ Hybridization Market 2023-2030 (Volume/Units)
3.2.3 Dna/Rna Microarray Market 2023-2030 (Volume/Units)
3.3 Next Generation Sequencing Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Mass Spectrometry Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Tumor Profiling Market, By Cancer Type Market 2023-2030 (Volume/Units)
4.1 Breast Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Lung Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Colorectal Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Prostate Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Melanoma Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Tumor Profiling Market, By Technology Market 2023-2030 ($M)
5.1 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
5.2 Hybridization Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Pcr Market 2023-2030 ($M)
5.2.2 In Situ Hybridization Market 2023-2030 ($M)
5.2.3 Dna/Rna Microarray Market 2023-2030 ($M)
5.3 Next Generation Sequencing Market 2023-2030 ($M) - Regional Industry Research
5.4 Mass Spectrometry Market 2023-2030 ($M) - Regional Industry Research
6.North America Tumor Profiling Market, By Cancer Type Market 2023-2030 ($M)
6.1 Breast Cancer Market 2023-2030 ($M) - Regional Industry Research
6.2 Lung Cancer Market 2023-2030 ($M) - Regional Industry Research
6.3 Colorectal Cancer Market 2023-2030 ($M) - Regional Industry Research
6.4 Prostate Cancer Market 2023-2030 ($M) - Regional Industry Research
6.5 Melanoma Cancer Market 2023-2030 ($M) - Regional Industry Research
7.South America Tumor Profiling Market, By Technology Market 2023-2030 ($M)
7.1 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
7.2 Hybridization Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Pcr Market 2023-2030 ($M)
7.2.2 In Situ Hybridization Market 2023-2030 ($M)
7.2.3 Dna/Rna Microarray Market 2023-2030 ($M)
7.3 Next Generation Sequencing Market 2023-2030 ($M) - Regional Industry Research
7.4 Mass Spectrometry Market 2023-2030 ($M) - Regional Industry Research
8.South America Tumor Profiling Market, By Cancer Type Market 2023-2030 ($M)
8.1 Breast Cancer Market 2023-2030 ($M) - Regional Industry Research
8.2 Lung Cancer Market 2023-2030 ($M) - Regional Industry Research
8.3 Colorectal Cancer Market 2023-2030 ($M) - Regional Industry Research
8.4 Prostate Cancer Market 2023-2030 ($M) - Regional Industry Research
8.5 Melanoma Cancer Market 2023-2030 ($M) - Regional Industry Research
9.Europe Tumor Profiling Market, By Technology Market 2023-2030 ($M)
9.1 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
9.2 Hybridization Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Pcr Market 2023-2030 ($M)
9.2.2 In Situ Hybridization Market 2023-2030 ($M)
9.2.3 Dna/Rna Microarray Market 2023-2030 ($M)
9.3 Next Generation Sequencing Market 2023-2030 ($M) - Regional Industry Research
9.4 Mass Spectrometry Market 2023-2030 ($M) - Regional Industry Research
10.Europe Tumor Profiling Market, By Cancer Type Market 2023-2030 ($M)
10.1 Breast Cancer Market 2023-2030 ($M) - Regional Industry Research
10.2 Lung Cancer Market 2023-2030 ($M) - Regional Industry Research
10.3 Colorectal Cancer Market 2023-2030 ($M) - Regional Industry Research
10.4 Prostate Cancer Market 2023-2030 ($M) - Regional Industry Research
10.5 Melanoma Cancer Market 2023-2030 ($M) - Regional Industry Research
11.APAC Tumor Profiling Market, By Technology Market 2023-2030 ($M)
11.1 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
11.2 Hybridization Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Pcr Market 2023-2030 ($M)
11.2.2 In Situ Hybridization Market 2023-2030 ($M)
11.2.3 Dna/Rna Microarray Market 2023-2030 ($M)
11.3 Next Generation Sequencing Market 2023-2030 ($M) - Regional Industry Research
11.4 Mass Spectrometry Market 2023-2030 ($M) - Regional Industry Research
12.APAC Tumor Profiling Market, By Cancer Type Market 2023-2030 ($M)
12.1 Breast Cancer Market 2023-2030 ($M) - Regional Industry Research
12.2 Lung Cancer Market 2023-2030 ($M) - Regional Industry Research
12.3 Colorectal Cancer Market 2023-2030 ($M) - Regional Industry Research
12.4 Prostate Cancer Market 2023-2030 ($M) - Regional Industry Research
12.5 Melanoma Cancer Market 2023-2030 ($M) - Regional Industry Research
13.MENA Tumor Profiling Market, By Technology Market 2023-2030 ($M)
13.1 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
13.2 Hybridization Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Pcr Market 2023-2030 ($M)
13.2.2 In Situ Hybridization Market 2023-2030 ($M)
13.2.3 Dna/Rna Microarray Market 2023-2030 ($M)
13.3 Next Generation Sequencing Market 2023-2030 ($M) - Regional Industry Research
13.4 Mass Spectrometry Market 2023-2030 ($M) - Regional Industry Research
14.MENA Tumor Profiling Market, By Cancer Type Market 2023-2030 ($M)
14.1 Breast Cancer Market 2023-2030 ($M) - Regional Industry Research
14.2 Lung Cancer Market 2023-2030 ($M) - Regional Industry Research
14.3 Colorectal Cancer Market 2023-2030 ($M) - Regional Industry Research
14.4 Prostate Cancer Market 2023-2030 ($M) - Regional Industry Research
14.5 Melanoma Cancer Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)2.Canada Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
3.Mexico Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
4.Brazil Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
5.Argentina Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
6.Peru Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
7.Colombia Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
8.Chile Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
9.Rest of South America Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
10.UK Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
11.Germany Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
12.France Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
13.Italy Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
14.Spain Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
15.Rest of Europe Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
16.China Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
17.India Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
18.Japan Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
19.South Korea Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
20.South Africa Cancer/Tumor Profiling Market Revenue, 2023-2030 ($M)
21.North America Cancer/Tumor Profiling By Application
22.South America Cancer/Tumor Profiling By Application
23.Europe Cancer/Tumor Profiling By Application
24.APAC Cancer/Tumor Profiling By Application
25.MENA Cancer/Tumor Profiling By Application
26.Illumina, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Qiagen N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Neogenomics Laboratories, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Htg Molecular Diagnostics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Genomic Health Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Caris Life Science, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Helomics Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Nanostring Technologies, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Oxford Gene Technology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Ribomed Biotechnologies, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)